Literature DB >> 8010334

An alternative approach to smoking control.

B Rodu1.   

Abstract

The detrimental health effects of cigarette smoking, including the increased risk of cancer, cardiovascular disorders, and pulmonary diseases, are well established. Although most smokers express a desire to quit, 46 million Americans continue to smoke because of the nicotine addiction associated with the habit. The author, in this paper, describes the magnitude of the health risks related to various forms of tobacco use and proposes that smokeless tobacco be recommended as a cigarette substitute by persons who cannot stop smoking. This proposal is made because smokeless tobacco is associated with far fewer and considerably less serious health consequences than is smoking. Of primary concern is oral cancer, the annual incidence of which is estimated at 26 cases per 100,000 smokeless tobacco users. If all American smokers used smokeless tobacco instead, this would result in 12,000 cases of oral cancer per year. This is only 1/20 of all smoking-related cancers, less than 1/10 of smoking-related lung cancers, and less than half the number of oral cancers now attributed to smoking. A public health policy that recognizes smokeless tobacco as an alternative to smoking would benefit individuals confronted with the unsatisfactory options of abstinence or continuing to smoke.

Entities:  

Mesh:

Year:  1994        PMID: 8010334     DOI: 10.1097/00000441-199407000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  10 in total

1.  Chewing tobacco: who uses and who quits? Findings from NHANES III, 1988-1994. National Health and Nutrition Examination Survey III.

Authors:  Beth Howard-Pitney; Marilyn A Winkleby
Journal:  Am J Public Health       Date:  2002-02       Impact factor: 9.308

2.  Estimating the health consequences of replacing cigarettes with nicotine inhalers.

Authors:  W Sumner
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

Review 3.  "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product.

Authors:  L T Kozlowski; B Q Edwards
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

4.  Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults.

Authors:  Carla J Berg; Regine Haardoerfer; Cam Escoffery; Pinpin Zheng; Michelle Kegler
Journal:  Nicotine Tob Res       Date:  2014-06-20       Impact factor: 4.244

5.  Trends in smokeless tobacco use among adults and adolescents in the United States.

Authors:  David E Nelson; Paul Mowery; Scott Tomar; Stephen Marcus; Gary Giovino; Luhua Zhao
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

6.  Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Authors:  Michael Kotlyar; Louise A Hertsgaard; Bruce R Lindgren; Joni A Jensen; Steven G Carmella; Irina Stepanov; Sharon E Murphy; Stephen S Hecht; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-10       Impact factor: 4.254

7.  Associations of Proposed Relative-Risk Warning Labels for Snus With Perceptions and Behavioral Intentions Among Tobacco Users and Nonusers.

Authors:  Brad Rodu; Nantaporn Plurphanswat; John R Hughes; Karl Fagerström
Journal:  Nicotine Tob Res       Date:  2015-08-07       Impact factor: 4.244

8.  The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.

Authors:  Mitchell Zeller; Dorothy Hatsukami
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

9.  Tobacco harm reduction: an alternative cessation strategy for inveterate smokers.

Authors:  Brad Rodu; William T Godshall
Journal:  Harm Reduct J       Date:  2006-12-21

10.  Permissive nicotine regulation as a complement to traditional tobacco control.

Authors:  Walton Sumner
Journal:  BMC Public Health       Date:  2005-02-24       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.